RT Journal Article
SR Electronic
T1 Virtual Epileptic Patient (VEP): Data-driven probabilistic personalized brain modeling in drug-resistant epilepsy
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.19.22269404
DO 10.1101/2022.01.19.22269404
A1 Huifang E Wang
A1 Marmaduke Woodman
A1 Paul Triebkorn
A1 Jean-Didier Lemarechal
A1 Jayant Jha
A1 Borana Dollomaja
A1 Anirudh Nihalani Vattikonda
A1 Viktor Sip
A1 Samuel Medina Villalon
A1 Meysam Hashemi
A1 Maxime Guye
A1 Julia Scholly
A1 Fabrice Bartolomei
A1 Viktor Jirsa
YR 2022
UL http://medrxiv.org/content/early/2022/01/21/2022.01.19.22269404.abstract
AB One-third of 50 million epilepsy patients worldwide suffer from drug resistant epilepsy and are candidates for surgery. Precise estimates of the epileptogenic zone networks (EZNs) are crucial for planning intervention strategies. Here, we present the Virtual Epileptic Patient (VEP), a multimodal probabilistic modeling framework for personalized end-to-end analysis of brain imaging data of drug resistant epilepsy patients. The VEP uses data-driven, personalized virtual brain models derived from patient-specific anatomical (such as T1-MRI, DW-MRI, and CT scan) and functional data (such as stereo-EEG). It employs Markov Chain Monte Carlo (MCMC) and optimization methods from Bayesian inference to estimate a patient’s EZN while considering robustness, convergence, sensor sensitivity, and identifiability diagnostics. We describe both high-resolution neural field simulations and a low-resolution neural mass model inversion. The VEP workflow was evaluated retrospectively with 53 epilepsy patients and is now being used in an ongoing clinical trial (EPINOV).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is funded through the European Union&'s Horizon 2020 Framework Programme for Research and Innovation under the Specific Grant Agreement No. 945539 (Human Brain Project SGA3) and the French National Research Agency (ANR) as part of the second Investissements d&'Avenir program (ANR-17-RHUS-0004, EPINOV).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Informed written consent was obtained for all patients in compliance with the ethical requirements of the Declaration of Helsinki and the study protocol was approved by the local Ethics Committee (Comite de Protection des Personnes sud Mediterranee 1).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAn example dataset used in the paper can be accessed at: https://doi.org/10.5281/zenodo.5816706. This data includes a patient's preprocessed anatomical and high-resolution functional simulation data. The patient raw datasets cannot be made publicly available due to the data protection concerns regarding potentially identifying and sensitive patient information. Interested researchers may access the data sets by contacting the corresponding authors. https://doi.org/10.5281/zenodo.5816706